Journal article
Does Renin‐Angiotensin System Blockade Protect Lupus Nephritis Patients From Atherosclerotic Cardiovascular Events? A Case–Control Study
Abstract
OBJECTIVE: Angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs) are used as an adjuvant treatment in lupus nephritis (LN) patients with proteinuria. The primary aim of this study was to discover whether ACE inhibitors/ARBs have an atheroprotective effect similar to other, at-risk, populations.
METHODS: A total of 144 patients (cases; mean ± SD age at onset 34 ± 12.1 years, followup 14.9 ± 8.6 years) with LN …
Authors
Tselios K; Gladman DD; Su J; Urowitz MB
Journal
Arthritis Care & Research, Vol. 68, No. 10, pp. 1497–1504
Publisher
Wiley
Publication Date
October 2016
DOI
10.1002/acr.22857
ISSN
2151-464X